Human B- and T-lymphocyte attenuator (BTLA)-Fc fusion protein, also known as CD272, GenBank Accession No. NM_181780, a.a. 31-150, expressed in a HEK293 cell expression system. MW = 40.3 kDa (monomer). This protein runs at a higher apparent M.W. by SDS-PAGE due to glycosylation.
| 产品名称 | BTLA(CD272), Fc fusion (Human) - Proteins - Immunotherapy |
| 产品货号 | 71141 |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | 100 µg |
| 产品品牌 | bpsbioscience |
| 产品概述 | |
| 产品详情 |
Species: Human
Host Species: HEK293
MW: 40.3 kDa
Genbank #: NM_181780
Tag(s): C-terminal Fc fusion (Human IgG1)
a.a: 31-150
Description: UniProt Q7Z6A9
Synonym(s): CD272
Endotoxin Level: <1 EU/µg Formulation: 40 mM Tris-HCl, pH 8.0,
110 mM NaCl, 2.2 mM KCl, and 20%
glycerol
Format: Aqueous buffer solution
Storage / Stability: At least 6 months at –80°C.
Application(s): Useful for the study of protein-protein interaction and in vitro and in vivo protein function studies.
Reference(s): 1. Flynn R, et al., PLoS One. 2013 Oct 29;8(10):77991. 2. Uchiyama M, et al., Transplantaion. 2014 Feb 15;97(3):301-9. Notes: The aggregation state of this product has been confirmed to be <10%.
Warning(s): Avoid freeze/thaw cycles. Protein may be diluted to ≥ 100 μg/ml in PBS + glycerol and stored at -80°C.
Scientific Category: Immunotherapy
Product Type: Recombinant Protein
Data shown is lot-specific. Contact us for specific information on other lots.
|
| 产品资料 |
